High-dose, short-, and long-term albumin infusions have shown significant mortality reduction in certain conditions such as SBP and type-1 HRS, but albumin’s impact on survival is less evident in other scenarios such as LVP and HE. Here, ALB is linked to hereditary elliptocytosis.